Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.
Identifieur interne : 000584 ( Main/Corpus ); précédent : 000583; suivant : 000585Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.
Auteurs : Stefano Piaserico ; Paolo Gisondi ; Simone Cazzaniga ; Luigi NaldiSource :
- American journal of clinical dermatology [ 1179-1888 ] ; 2020.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Betacoronavirus (MeSH), Biological Therapy (adverse effects), Cohort Studies (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (etiology), Female (MeSH), Humans (MeSH), Italy (epidemiology), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Pneumonia, Viral (etiology), Psoriasis (drug therapy), Tumor Necrosis Factor Inhibitors (adverse effects), Young Adult (MeSH).
- MESH :
- chemical , adverse effects : Tumor Necrosis Factor Inhibitors.
- geographic , epidemiology : Italy.
- adverse effects : Biological Therapy.
- drug therapy : Psoriasis.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- etiology : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, Betacoronavirus, Cohort Studies, Female, Humans, Male, Middle Aged, Pandemics, Young Adult.
DOI: 10.1007/s40257-020-00552-w
PubMed: 32812188
PubMed Central: PMC7433672
Links to Exploration step
pubmed:32812188Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.</title>
<author><name sortKey="Piaserico, Stefano" sort="Piaserico, Stefano" uniqKey="Piaserico S" first="Stefano" last="Piaserico">Stefano Piaserico</name>
<affiliation><nlm:affiliation>Unit of Dermatology, Department of Medicine, University of Padua, via Gallucci 4, 35128, Padova, Italy. stefano.piaserico@unipd.it.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gisondi, Paolo" sort="Gisondi, Paolo" uniqKey="Gisondi P" first="Paolo" last="Gisondi">Paolo Gisondi</name>
<affiliation><nlm:affiliation>Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cazzaniga, Simone" sort="Cazzaniga, Simone" uniqKey="Cazzaniga S" first="Simone" last="Cazzaniga">Simone Cazzaniga</name>
<affiliation><nlm:affiliation>Centro Studi GISED, Bergamo, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Inselspital University Hospital of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Naldi, Luigi" sort="Naldi, Luigi" uniqKey="Naldi L" first="Luigi" last="Naldi">Luigi Naldi</name>
<affiliation><nlm:affiliation>Centro Studi GISED, Bergamo, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32812188</idno>
<idno type="pmid">32812188</idno>
<idno type="doi">10.1007/s40257-020-00552-w</idno>
<idno type="pmc">PMC7433672</idno>
<idno type="wicri:Area/Main/Corpus">000584</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000584</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.</title>
<author><name sortKey="Piaserico, Stefano" sort="Piaserico, Stefano" uniqKey="Piaserico S" first="Stefano" last="Piaserico">Stefano Piaserico</name>
<affiliation><nlm:affiliation>Unit of Dermatology, Department of Medicine, University of Padua, via Gallucci 4, 35128, Padova, Italy. stefano.piaserico@unipd.it.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gisondi, Paolo" sort="Gisondi, Paolo" uniqKey="Gisondi P" first="Paolo" last="Gisondi">Paolo Gisondi</name>
<affiliation><nlm:affiliation>Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cazzaniga, Simone" sort="Cazzaniga, Simone" uniqKey="Cazzaniga S" first="Simone" last="Cazzaniga">Simone Cazzaniga</name>
<affiliation><nlm:affiliation>Centro Studi GISED, Bergamo, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Inselspital University Hospital of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Naldi, Luigi" sort="Naldi, Luigi" uniqKey="Naldi L" first="Luigi" last="Naldi">Luigi Naldi</name>
<affiliation><nlm:affiliation>Centro Studi GISED, Bergamo, Italy.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">American journal of clinical dermatology</title>
<idno type="eISSN">1179-1888</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Biological Therapy (adverse effects)</term>
<term>Cohort Studies (MeSH)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (etiology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Italy (epidemiology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (etiology)</term>
<term>Psoriasis (drug therapy)</term>
<term>Tumor Necrosis Factor Inhibitors (adverse effects)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Tumor Necrosis Factor Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Italy</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Biological Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Psoriasis</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Betacoronavirus</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32812188</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1179-1888</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>21</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>American journal of clinical dermatology</Title>
<ISOAbbreviation>Am J Clin Dermatol</ISOAbbreviation>
</Journal>
<ArticleTitle>Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.</ArticleTitle>
<Pagination><MedlinePgn>749-751</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s40257-020-00552-w</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piaserico</LastName>
<ForeName>Stefano</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-1091-4733</Identifier>
<AffiliationInfo><Affiliation>Unit of Dermatology, Department of Medicine, University of Padua, via Gallucci 4, 35128, Padova, Italy. stefano.piaserico@unipd.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gisondi</LastName>
<ForeName>Paolo</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cazzaniga</LastName>
<ForeName>Simone</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Centro Studi GISED, Bergamo, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Inselspital University Hospital of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Naldi</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Centro Studi GISED, Bergamo, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>New Zealand</Country>
<MedlineTA>Am J Clin Dermatol</MedlineTA>
<NlmUniqueID>100895290</NlmUniqueID>
<ISSNLinking>1175-0561</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001691" MajorTopicYN="N">Biological Therapy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011565" MajorTopicYN="N">Psoriasis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32812188</ArticleId>
<ArticleId IdType="doi">10.1007/s40257-020-00552-w</ArticleId>
<ArticleId IdType="pii">10.1007/s40257-020-00552-w</ArticleId>
<ArticleId IdType="pmc">PMC7433672</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2020 Jun;20(6):345-346</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32358580</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 2;395(10234):1407-1409</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32278362</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Dermatol. 2020 Aug;183(2):373-374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32343839</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2020 May;94:91-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32173574</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Acad Dermatol. 2020 Aug;83(2):677-679</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32416207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Gastroenterol. 2013 Aug;108(8):1268-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23649185</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000584 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000584 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidSeniorV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32812188 |texte= Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32812188" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidSeniorV1
![]() | This area was generated with Dilib version V0.6.37. | ![]() |